Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iraq Healthcare Wire.
Press releases published on September 2, 2025
Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO
GlobeNewswire
·
September 2, 2025
MENLO PARK, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform …
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …
Picard Medical, Inc. Announces Closing of $17 Million Initial Public Offering
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (“Picard” or the “Company”), today announced that it closed its initial public offering of 4,250,000 shares of common stock, par value $0.0001 per share (the “ …
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted two newly-hired employees options to purchase an …
Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
September 2, 2025
ORLANDO, Fla., Sept. 02, 2025 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”) today announced that a majority of the independent members of LENSAR’s board of directors granted three newly-hired non-executive employees an …
Cognition Therapeutics Closes $30 Million Registered Direct Offering to Two New Fundamental Institutional Investors, Including a Preeminent Global Investment Firm to Support Phase 3 Development of Zervimesine (CT1812)
GlobeNewswire
·
September 2, 2025
PURCHASE, N.Y., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, closed its previously announced registered …
Harms from Modified mRNA COVID-19 Vaccines Discussed in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Experience to date indicates that modified mRNA COVID-19 vaccines can disrupt every body system, and that urgent scrutiny and accountability are needed, write Andrew Zywiec, M.D., and others in the fall …
The Implications of Artificial Intelligence (AI) for Medicine Discussed in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Artificial intelligence (AI) is envisioned by many to be the future of medicine, and it is critical to understand its implications and the background of technocracy, which AI will serve, writes Patrick Wood …
Evidence for ‘Chemtrails’ Examined in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- The “chemtrails” theory gained prominence in the Make America Healthy Again (MAHA) movement, leading to the enactment of related legislative measures. In the fall issue of the Journal of American Physicians …
Expert on Sham Peer Review Discusses Tactic of Not Allowing Doctor’s Attorney to Speak, in the Journal of American Physicians and Surgeons
GlobeNewswire
·
September 2, 2025
TUCSON, Ariz., Sept. 02, 2025 (GLOBE NEWSWIRE) -- A physician who is a victim of sham peer review at his hospital may be shocked to learn that some medical staff bylaws prohibit the physician’s attorney from speaking at the peer review hearing, writes …
UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller, Sponsored by Rockefeller Global Family Office
GlobeNewswire
·
September 2, 2025
NRx CEO presented plans for HOPE Therapeutics rollout in September 2025 and establishment of flagship location in Palm Beach, FL during symposium presentation with leadership from Rockefeller Capital and Matthew Rockefeller. Company has recently raised $8. …
Chronic Gout Market to Witness Strong Growth by 2034 Owing to the Expected Launch of Therapies including mTOR Inhibitors and URAT1 Inhibitors | DelveInsight
GlobeNewswire
·
September 2, 2025
New York, USA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Chronic Gout Market to Witness Strong Growth by 2034 Owing to the Expected Launch of Therapies including mTOR Inhibitors and URAT1 Inhibitors | DelveInsight The chronic gout market is expected to maintain a …
QHSLab (OTCQB: USAQ) Rolls Out Breakthrough Pediatric Screening Tool Linking Allergies and Mental Health
GlobeNewswire
·
September 2, 2025
Back-to-School Season Just Got Smarter The Pediatric Health Assessment empowers parents and providers to uncover hidden health or behavioral issues that may affect academic and social success. QHSLab’s platform delivers critical insights at the perfect …
Precipio Terminates Its ATM
GlobeNewswire
·
September 2, 2025
NEW HAVEN, Conn., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), has terminated its ATM (At-The-Market) instrument with investment bank Alliance Global Partners (AGP). “Our Company is in a much …
Trinity Biotech Regains Compliance with Nasdaq Listing Requirements
GlobeNewswire
·
September 2, 2025
DUBLIN, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq Global Select: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced that it has …
Ethos Cannabis and Thomas Jefferson University to Co-Host Pennsylvania Medical Marijuana Education & Research Summit
GlobeNewswire
·
September 2, 2025
As Pennsylvania’s Cannabis Market Evolves, Shapiro Administration Deputy Secretary Meghna Patel and Other Experts Lead Dialogue on Medical Cannabis Policy, Research, and Patient Access Summit to Take Place on September 5, 2025, at Thomas Jefferson …
Senti Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, …
Femasys Closes $8 Million in Financing to Accelerate Commercialization of Fertility and Birth Control Portfolios
GlobeNewswire
·
September 2, 2025
--Existing investors, including Femasys’ largest shareholders, reaffirm confidence in Femasys’ strategy for growth and impact in women’s health-- ATLANTA, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making …
KidneyVault Perfusion Technology Expands the Donor Pool by Increasing Access to Medically Complex Kidneys
GlobeNewswire
·
September 2, 2025
WALTHAM, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Paragonix Technologies, a leader in advanced organ preservation and transplant logistics, reports an extraordinary case at the Tampa General Hospital Transplant Institute in which a donor kidney underwent …